Collectively, these findings establish that SAMD4B facilitates breast cancer cell proliferation by upregulating G1-phase Cyclin-CDK complexes, thereby accelerating G1-S phase transition and driving cell cycle progression. Here, SAMD4B is linked to breast carcinoma.